Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 149 participants.

Also called NCT05421130

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 149 participants (planned count) (from the registry)
Sponsor
  • Avania Registry lists this organization as a collaborator
Registry
  • NCT NCT05421130
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany, Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05421130. Allocation not applicable; no masking; primary purpose treatment. Start 2022-05-02 (actual); primary completion 2023-07-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair
Condition
Aortic Aneurysm
Condition
Aortic Arch Aneurysm
Condition
Aortic Arch; Aneurysm, Dissecting
Intervention (Device)
Selective Cerebral Perfusion Catheter
Lead sponsor
Fuji Systems Corporation (class: industry)
Collaborator
Avania (class: industry)

Record details

Record id
cardio:ct-nct05421130
Content hash
79f3ae0325924834f97d1c19e8b7756aa3c4779510b8e860c9159146fec77ae0